Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections

被引:173
作者
Mueller, B.
Morgenthaler, N.
Stolz, D.
Schuetz, P.
Mueller, C.
Bingisser, R.
Bergmann, A.
Tamm, M.
Christ-Crain, M. [1 ]
机构
[1] Univ Basel Hosp, Dept Internal Med, Petersgraben 4, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Div Pneumol, CH-4031 Basel, Switzerland
[3] Brahms AG, Dept Res, Hennigsdorf, Germany
关键词
biomarkers; pneumonia; prognosis; respiratory tract infections;
D O I
10.1111/j.1365-2362.2007.01762.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Vasopressin has haemodynamic as well as osmoregulatory effects, and reflects the individual stress response. Copeptin is cosynthesized with vasopressin, directly mirroring vasopressin levels, but is more stable in plasma and serum. Both levels are increased in patients with septic shock. Lower respiratory tract infections (LRTI) are a precursor of sepsis. Thus, we investigated circulating levels and the prognostic use of copeptin for the severity and outcome in patients with LRTI. Materials and methods Five hundred and forty-five consecutive patients with LRTI and 50 healthy controls were evaluated. Serum copeptin levels were measured with a new chemiluminescens sandwich immunoassay. Results Of the 545 patients, 373 had community-acquired pneumonia (CAP), 60 acute exacerbations of chronic obstructive pulmonary disease (COPD), 59 acute bronchitis, 13 exacerbations of asthma and 40 other final diagnoses. Copeptin levels were significantly higher in patients with LRTI as compared to controls (P < 0.001) with highest levels in patients with CAP. Copeptin levels increased with increasing severity of CAP, as classified by the pneumonia severity index (PSI) (P < 0.001). In patients who died, copeptin levels on admission were significantly higher as compared to levels in survivors [70.0 (28.8-149.0) vs. 24.3 (10.8-43.8) pmol L-1, P < 0.001]. The area under the receiver operating curve (AUC) for survival was 0.75 for copeptin, which was significantly higher as compared to C-reactive protein (AUC 0.61, P = 0.01), leukocyte count (AUC 0.59, P = 0.01) and similar to procalcitonin (AUC 0.68, P = 0.21). Conclusions Copeptin levels are increased with increasing severity of LRTI namely in patients with CAP and unfavourable outcome. Copeptin levels, as a novel biomarker, might be a useful tool in the risk stratification of patients with LRTI.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 39 条
[1]   Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia [J].
Almirall, J ;
Bolíbar, I ;
Toran, P ;
Pera, G ;
Boquet, X ;
Balanzó, X ;
Sauca, G .
CHEST, 2004, 125 (04) :1335-1342
[2]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[3]   Chronic obstructive pulmonary disease [J].
Calverley, PMA ;
Walker, P .
LANCET, 2003, 362 (9389) :1053-1061
[4]  
Chikanza IC, 2000, ANN NY ACAD SCI, V917, P825
[5]   Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:: cluster-randomised, single-blinded intervention trial [J].
Christ-Crain, M ;
Jaccard-Stolz, D ;
Bingisser, R ;
Gencay, MM ;
Huber, PR ;
Tamm, M ;
Müller, B .
LANCET, 2004, 363 (9409) :600-607
[6]  
Christ-Crain M, 2005, SWISS MED WKLY, V135, P451
[7]   Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia a Randomized trial [J].
Christ-Crain, Miriam ;
Stolz, Daiana ;
Bingisser, Roland ;
Muller, Christian ;
Miedinger, David ;
Huber, Peter R. ;
Zimmerli, Werner ;
Harbarth, Stephan ;
Tamm, Michael ;
Mueller, Beat .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (01) :84-93
[8]  
CHRISTCRAIN M, 2006, 88 ANN M END SOC END
[9]   Structure-function relationships of the vasopressin prohormone domains [J].
de Bree, FM ;
Burbach, JPH .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 1998, 18 (02) :173-191
[10]   ROLE OF BLOOD OSMOLALITY AND VOLUME IN REGULATING VASOPRESSIN SECRETION IN RAT [J].
DUNN, FL ;
BRENNAN, TJ ;
NELSON, AE ;
ROBERTSON, GL .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (12) :3212-3219